Recent advances and current controversies in the management of DCIS of the breast.
about
Progression of ductal carcinoma in situ to invasive breast cancer is associated with gene expression programs of EMT and myoepithelia.A potential role for human UDP-glucuronosyltransferase 1A4 promoter single nucleotide polymorphisms in the pharmacogenomics of tamoxifen and its derivativesEffect of tamoxifen and radiotherapy in women with locally excised ductal carcinoma in situ: long-term results from the UK/ANZ DCIS trial.Update on DCIS outcomes from the American Society of Breast Surgeons accelerated partial breast irradiation registry trial.RNA-Seq of human breast ductal carcinoma in situ models reveals aldehyde dehydrogenase isoform 5A1 as a novel potential target.Combined inhibition of ErbB1/2 and Notch receptors effectively targets breast ductal carcinoma in situ (DCIS) stem/progenitor cell activity regardless of ErbB2 status.Identification of early molecular markers for breast cancer.Association of RB/p16-pathway perturbations with DCIS recurrence: dependence on tumor versus tissue microenvironment.Effect of radiotherapy on survival of women with locally excised ductal carcinoma in situ of the breast: a Surveillance, Epidemiology, and End Results population-based analysisIncreased SIAH expression predicts ductal carcinoma in situ (DCIS) progression to invasive carcinoma.Breast Ductal Carcinoma In Situ: A Literature Review of Adjuvant Hormonal Therapy.Choices in surgery for older women with breast cancer.KX-01, a novel Src kinase inhibitor directed toward the peptide substrate site, synergizes with tamoxifen in estrogen receptor α positive breast cancer.Benefit of low-dose tamoxifen in a large observational cohort of high risk ER positive breast DCIS.Docking of CDK1 with antibiotic drugs revealed novel therapeutic value in breast ductal cancer in situ.Value of shear wave elastography in discriminating malignant and benign breast lesions: A meta-analysis.Molecular imaging with a fluorescent antibody targeting carbonic anhydrase IX can successfully detect hypoxic ductal carcinoma in situ of the breast.Benign and malignant breast lesions identification through the values derived from shear wave elastography: evidence for the meta-analysis.Detection and clinical relevance of hematogenous tumor cell dissemination in patients with ductal carcinoma in situ.Hematogenous and lymphatic tumor cell dissemination may be detected in patients diagnosed with ductal carcinoma in situ of the breast.
P2860
Q34088976-C99177A2-3780-4AAA-9B28-A5D1A2E317E8Q34125047-4E1F884E-7D54-4A16-B9E3-6AD229B2FBAEQ34478845-7DD52672-A401-4913-A936-3FA6A590F50EQ34482307-E8AF7447-A987-4FF0-B130-5776460E80DAQ34510318-B29148BE-7DEF-49FF-894C-F125D64EEAA5Q34607133-4AEE29F8-5B52-41A1-AF1C-AABDD0EEDFF4Q34608080-C430A6A3-EBBB-4336-AEDF-8655965A9BF0Q35168174-A6EC9DD9-121E-4E43-A0B0-6367F79C6ED2Q35743243-BA7DD3B8-5289-4D36-83FE-FEBDA0545018Q37062990-34B7F9AC-AB21-4A74-A2A6-3249DBF5EB60Q37527260-B349AB77-64BD-441C-A4CA-A51DD24F9669Q37677722-0D365354-FE0F-47A2-B67E-F773A7C248EEQ39555328-200074D5-A8B1-4EE0-8135-6D387F1C1553Q40665794-4779CC18-B303-41D0-8F26-4B8447D26552Q42365316-2AD33141-7D8F-41C5-8E08-C051AC9BBA2DQ43773191-FE3C6A4C-0ECB-42E2-8851-DD3419DE2833Q46557148-84B28B38-AFC6-46C2-A236-455E1EB4BC8FQ47137593-2F4C98B4-E69C-44BC-A421-0C1CA4615BEEQ50715430-6898562A-E861-4E90-B7AC-BCE8D5842807Q51043480-B6842AA7-0C2D-4706-80BA-AF59457E1A35
P2860
Recent advances and current controversies in the management of DCIS of the breast.
description
2008 nî lūn-bûn
@nan
2008 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Recent advances and current controversies in the management of DCIS of the breast.
@ast
Recent advances and current controversies in the management of DCIS of the breast.
@en
Recent advances and current controversies in the management of DCIS of the breast.
@nl
type
label
Recent advances and current controversies in the management of DCIS of the breast.
@ast
Recent advances and current controversies in the management of DCIS of the breast.
@en
Recent advances and current controversies in the management of DCIS of the breast.
@nl
prefLabel
Recent advances and current controversies in the management of DCIS of the breast.
@ast
Recent advances and current controversies in the management of DCIS of the breast.
@en
Recent advances and current controversies in the management of DCIS of the breast.
@nl
P2093
P1476
Recent advances and current controversies in the management of DCIS of the breast.
@en
P2093
David R Farley
George H Sakorafas
George Peros
P304
P356
10.1016/J.CTRV.2008.03.001
P577
2008-05-19T00:00:00Z